Regeneron Pharmaceuticals (REGN)
(Delayed Data from NSDQ)
$1,146.75 USD
-6.33 (-0.55%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $1,146.77 +0.02 (0.00%) 6:40 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Brokerage Reports
Regeneron Pharmaceuticals, Inc. [REGN]
Reports for Purchase
Showing records 321 - 340 ( 596 total )
Company: Regeneron Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Regeneron Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Regeneron Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Regeneron Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Regeneron Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Regeneron Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Regeneron Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Regeneron Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Regeneron Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Regeneron Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Global Week Ahead: A Lazy, Unfocused Summer is Here, companies mentioned- AVGO, REGN, VOD
Provider: ZACKS INVESTMENT RESEARCH
Company: Regeneron Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Global Week Ahead: Don''t Be Rip Van Winkle, companies mentioned- AMT, REGN, INTU
Provider: ZACKS INVESTMENT RESEARCH